Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease

被引:8
|
作者
Liu, Xi [1 ]
Shen, Ling [1 ]
Han, Bing [1 ]
Yao, Honghong [1 ]
机构
[1] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China
来源
NON-CODING RNA RESEARCH | 2021年 / 6卷 / 03期
关键词
Noncoding RNA; Blood-brain barrier; Central nervous system disease; INTRINSIC ANTIVIRAL IMMUNITY; TUMOR BARRIER; TIGHT JUNCTIONS; INTRACEREBRAL HEMORRHAGE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; PERMEABILITY; EXPRESSION; DISRUPTION; INJURY;
D O I
10.1016/j.ncrna.2021.06.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Given the important role of the blood-brain barrier (BBB) in the central nervous system (CNS), increasing studies have been carried out to determine how the structural and functional integrity of the BBB impacts the pathogenesis of CNS diseases such as stroke, traumatic brain injuries (TBIs), and gliomas. Emerging studies have revealed that noncoding RNAs (ncRNAs) help to maintain the integrity and permeability of the BBB, thereby mediating CNS homeostasis. This review summarizes recent studies that focus on the effects of ncRNAs on the BBB in CNS diseases, including regulating the biological processes of inflammation, necrosis, and apoptosis of cells, affecting the translational dysfunction of proteins and regulating tight junctions (TJs). A comprehensive and detailed understanding of the interaction between ncRNAs and the BBB will lay a solid foundation for the development of early diagnostic methods and effective treatments for CNS diseases.
引用
收藏
页码:130 / 138
页数:9
相关论文
共 50 条
  • [31] Regulation of the Blood-Brain Barrier: New Treatments for Central Nervous System Neoplasms
    Kalra, Ricky
    Couldwell, William T.
    WORLD NEUROSURGERY, 2011, 75 (02) : 179 - 180
  • [33] BLOOD-BRAIN BARRIER AND GROUND SUBSTANCE OF CENTRAL NERVOUS SYSTEM - SIMILARITIES IN DEVELOPMENT
    HESS, A
    ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1955, 73 (APR): : 380 - 386
  • [34] Glucocorticoid signalling and resistance at the blood-brain barrier in central nervous system disorders
    Kleinschnitz, Christoph
    Blecharz, Kinga
    Kahles, Timo
    Schwarz, Tobias
    Kraft, Peter
    Goebel, Kerstin
    Meuth, Sven G.
    Burek, Malgorzata
    Tha, Serge
    Scheffer, David
    Thum, Thomas
    Stoll, Guido
    Foerster, Carola
    VASCULAR PHARMACOLOGY, 2012, 56 (5-6) : 355 - 355
  • [35] DIFFERENCES IN EFFECTIVITY OF THE BLOOD-BRAIN BARRIER IN DIFFERENT PARTS OF CENTRAL NERVOUS SYSTEM
    Brattgard, Sven-Olof
    Lindqvist, Torsten
    ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA, 1955, 30 (03): : 423 - 436
  • [36] Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases
    Segura-Collar, Berta
    Mata-Martinez, Pablo
    Hernandez-Lain, Aurelio
    Sanchez-Gomez, Pilar
    Gargini, Ricardo
    NEUROSCIENTIST, 2022, 28 (03): : 222 - 237
  • [37] ABSENCE OF BLOOD-BRAIN BARRIER FROM CERTAIN AREAS OF CENTRAL NERVOUS SYSTEM
    WILSON, CW
    BRODIE, BB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1961, 133 (03): : 332 - &
  • [38] Exposure of quantum dots in the nervous system: Central nervous system risks and the blood-brain barrier interface
    Guan, Shujing
    Tang, Meng
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (07) : 936 - 952
  • [39] The integrity of the blood-brain barrier in Alzheimer's disease
    Algotsson, A.
    Winblad, B.
    ACTA NEUROLOGICA SCANDINAVICA, 2007, 115 (06): : 403 - 408
  • [40] Central nervous system complications of diabetes mellitus - A perspective from the blood-brain barrier
    Mooradian, AD
    BRAIN RESEARCH REVIEWS, 1997, 23 (03) : 210 - 218